Australia Stock Exchange release from ALTERITY THERAPE : First Regulatory Authorization to Proceed with Phase 2 Trial
13/12/2021 22:41
Australia Stock Exchange release from ALTERITY THERAPE ATH.AX : First Regulatory Authorization to Proceed with Phase 2 Trial
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital